Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Learn how colon cancer patients can reap the benefits of exercise, potentially raising the chances of survival post-surgery ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Experts say findings, presented at the ongoing American Society of Clinical Oncology (ASCO) annual meeting in Chicago, have ...

AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

With the American Society of Clinical Oncology (ASCO) annual meeting in full swing at Chicago’s McCormick Place this past ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...